Skip to main content

A Phase 2 Study of IkT-148009 in Untreated Parkinson¿s Disease

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Movement Disorders

Awarded By

Inhibikase Therapeutics, Inc.

Start Date

November 22, 2022

End Date

September 1, 2025
 

Administered By

Neurology, Movement Disorders

Awarded By

Inhibikase Therapeutics, Inc.

Start Date

November 22, 2022

End Date

September 1, 2025